Cite
MLA Citation
Neha Korde et al.. “Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone.” American journal of hematology, vol. 96, no. 6, 2021, pp. E193–E196. http://access.bl.uk/ark:/81055/vdc_100130155070.0x00004b